MINNEAPOLIS--(BUSINESS WIRE)--CVRx, Inc., a private medical device company, has named Todd Langevin senior vice president of clinical and commercial development, effective immediately. Langevin is overseeing the pivotal clinical trial of the Rheos™ Baroreflex Hypertension Therapy™ System, the only implantable device designed to control hypertension, a leading cause of heart and kidney disease, stroke and death.
